Results 41 to 50 of about 543,609 (231)

Striatal phosphodiesterase 10A availability is altered secondary to chronic changes in dopamine neurotransmission

open access: yesEJNMMI Radiopharmacy and Chemistry, 2016
Background Phosphodiesterase 10A (PDE10A) is an important regulator of nigrostriatal dopamine (DA) neurotransmission. However, little is known on the effect of alterations in DA neurotransmission on PDE10A availability. Here, we used [18F]JNJ42259152 PET
Maarten Ooms   +11 more
doaj   +1 more source

Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms [PDF]

open access: yes, 2014
Depression has been associated with drug consumption, including heavy or problematic cannabis use. According to an animal model of depression and substance use disorder comorbidity, we combined the olfactory bulbectomy (OBX) model of depression with ...
Amchova P   +11 more
core   +1 more source

Recurrent Syncope following Substance Abuse; a Case Report

open access: yesEmergency, 2016
Drug abuse is considered as the most common poisoning in the world. Stimulants agent especially amphetamines and methamphetamines are among important abused substances.
Forod Salehi   +3 more
doaj   +3 more sources

Neural Models of Normal and Abnormal Behavior: What Do Schizophrenia, Parkinsonism, Attention Deficit Disorder, and Depression Have in Common? [PDF]

open access: yes, 1998
Defense Advanced Research Projects Agency and Office of Naval Research (N00014-95-1-0409); National Science Foundation (IRI-97 ...
Abbott   +177 more
core   +2 more sources

Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders.

open access: yesCochrane Database of Systematic Reviews, 2018
BACKGROUND Amphetamine-type stimulants (ATS) refer to a group of synthetic stimulants including amphetamine, methamphetamine, 3,4-methylenedioxy-methamphetamine (MDMA) and related substances.
T. Harada   +3 more
semanticscholar   +1 more source

Time Perception and Psychiatric Disorders [PDF]

open access: yesPsikiyatride Güncel Yaklaşımlar, 2013
Time perception is an ability which we use in every moment of daily life, that guides the formation and continuation of our behaviors and from an evolutionary perspective ensures survival. Internal clock models help us to understand time perception. Time
Hatice Ceviz   +3 more
doaj   +1 more source

Amphetamine, but not methylphenidate, increases ethanol intake in adolescent male, but not in female, rats [PDF]

open access: yes, 2018
Introduction: There has been an increasing interest in analyzing the interactions between stimulants and ethanol during childhood and adolescence. Stimulants are used to treat attention-deficit hyperactivity disorder (ADHD) in these developmental stages,
Acevedo   +77 more
core   +1 more source

Cognitive‐behavioural treatment for amphetamine‐type stimulants (ATS)‐use disorders

open access: yesCampbell Systematic Reviews, 2019
Background Amphetamine‐type stimulants (ATS) refer to a group of synthetic stimulants including amphetamine, methamphetamine, 3,4‐methylenedioxy‐methamphetamine (MDMA) and related substances.
Takayuki Harada   +3 more
semanticscholar   +1 more source

Amphetamine alters the Reward Positivity in humans and mice

open access: yesbioRxiv, 2021
The development of pro-cognitive therapeutics for psychiatric disorders has been beset with difficulties. This is in part due to the absence of pharmacologically-sensitive cognitive biomarkers common to humans and rodents.
J. Cavanagh   +12 more
semanticscholar   +1 more source

Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users. [PDF]

open access: yes, 2015
Dysfunction of the mesocorticolimbic system has a critical role in clinical features of addiction. Despite evidence suggesting that midbrain dopamine receptors influence amphetamine-induced dopamine release and that dopamine is involved in ...
Dean, AC   +5 more
core   +4 more sources

Home - About - Disclaimer - Privacy